TUCSON   520.748.4400

Biotechnology

RCT’s investments in the field of biotechnology include:

asNzodoJ_400x400

Aragen Bioscience, LLC

Aragen Bioscience offers cell line development, protein expression and purification, molecular biology, cell biology immunology, and diverse in vivo services to the biotech and pharmaceutical industries. Corporate offices and in vitro laboratories are located in Morgan Hill, California at the south end of Silicon Valley. Aragen and its predecessor, Sierra BioSource, have been operating in ...

biocision

BioCision

BioCision is developing technologies and products to standardize pre-analytical sample handling. BioCision’s first products, the CoolRack® line, are made from a novel aluminum alloy that is 300 times more conductive than ice and adapts rapidly to the temperature of any freezing or cooling medium. The CoolRack® line includes thermo-conductive modules that hold tube or plate ...

logo

BioInformatics, LLC

Since 1994, BioInformatics LLC has provided critical market intelligence to major suppliers serving the life science, medical device and pharmaceutical industries. The company supports clients across the entire market spectrum — from scientific research to diagnostics and therapeutics — providing high-level management with strategic market insights. BioInformatics offers both custom market research services as well ...

catalyst-biosciences

Catalyst Biosciences Inc.

Catalyst Biosciences Inc. is a San Francisco company formed around proprietary technology exclusively licensed from the University of California, San Francisco, to develop engineered proteases as a new class of protein therapeutics. Proteases are naturally occurring protein-degrading enzymes that are catalytic in nature. Each protease molecule is capable of inactivating hundreds to thousands of target molecules, ...

_get_company_logo

DisperSol Technologies, LLC

DisperSol Technologies was founded in 2007 and evolved from a research collaboration with the College of Pharmacy at The University of Texas at Austin. The focus of this collaboration was to adapt and apply a unique plastics processing technology to pharmaceutical manufacturing. KinetiSol® emerged from this research as an innovative technology for the production of ...

esperance

Esperance Pharmceuticals

Esperance Pharmaceuticals is developing a bi-functional targeted oncolytic protein platform using its cationic lytic peptide (CLYP™) technology. Esperance’s conjugated proteins consist of two domains, a cancer cell targeting domain such as a receptor ligand or antibody, and a cell membrane disrupting domain. The company’s lead drug is EP-100 which targets the LHRH-Receptor on ovarian, endometrial ...

Femtogenix-Landscape-RGB

Femtogenix, Ltd.

Femtogenix, Ltd. was founded in 2015 as a spin-out company from King’s College London (KCL) with RCT providing the initial Series A investment. The focus of the company is to discover and develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates. The payload molecules are designed through a development platform combining proprietary ...

activities-logos-GSD

Gold Standard Diagnostics, Corp.

Gold Standard Diagnostics, based in Davis, California, has developed a unique diagnostic instrument called the ThunderBolt that meets a niche need in the in vitro Diagnostics market. The ThunderBolt is a comparatively low-cost, highly flexible instrument that provides a comprehensive solution for clinical labs to automate low to medium volume IVD assays. Gold Standard Diagnostics ...

jenrin-discovery

Jenrin Discovery Inc.

Jenrin Discovery is a privately owned emerging pharmaceutical company focused on developing safer and more effective therapeutics for a variety of chronic diseases, including obesity, diabetes and autoimmune/inflammatory disorders. The company uses a proprietary technology to develop orally effective small molecule derivatives of currently marketed drugs. This approach significantly reduces the time and investment required to ...

activities-logos-ORFLO

Orflo Technologies, LLC

ORFLO Technologies is a privately held leading edge biotechnology company with a mission to revolutionize cell analysis. The first product developed by ORFLO was licensed to a third-party and launched in 2010 as the first of its kind hand-held cell counter. After this product received many industry awards for innovation, and high accolades from the ...

investments-logos-Selah

Selah Genomics, Inc.

Selah Genomics is a clinical diagnostic specialist supporting healthcare providers and the pharmaceutical industry with advanced molecular and genomic diagnostic services. Selah’s services add value to early stage drug development, clinical trials and regulatory processes in the pharmaceutical industry and helps clinicians and healthcare providers treat and monitor patients, thereby improving patient outcomes. With the ...

logo

The BroadOak Fund, LLC

RCT has partnered with BroadOak Capital Partners, LLC in the funding of The BroadOak Fund, LLC, an investment fund formed to provide growth capital to life sciences tools and service providers primarily through flexible debt structures.   The BroadOak Fund is managed by BroadOak Capital Partners, LLC, a firm that actively invests in life sciences companies ...

activities-logos-TONBO

Tonbo Biosciences, Inc.

Founded in 2011 by a team of immunologists, researchers and industry leaders, Tonbo Biosciences was conceived of a simple principle: giving back to the research community by providing high performance, value oriented products of the highest quality. Tonbo operates in the flow cytometry reagent marketplace, producing and selling the top 500 flow cytometry antibodies. Tonbo ...

RCT also has various Historic Investments.